期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Effects of Zhenggan Huayu decoction(正肝化瘀方)combined with entecavir on gut microbiota in patients with chronic hepatitis B fibrosis 被引量:1
1
作者 CHEN Wenlin LIANG Fang +2 位作者 ZHANG Yuncheng lv jinzhen YANG Daguo 《Journal of Traditional Chinese Medicine》 SCIE CSCD 2023年第3期559-567,共9页
OBJECTIVE:To evaluate the effects of Zhenggan Huayu decoction(正肝化瘀方,ZGHY) combined with entecavir(ETV) on the gut microbiota in patients with chronic hepatitis B(CHB) fibrosis.METHODS:A total of 59 CHB-related fi... OBJECTIVE:To evaluate the effects of Zhenggan Huayu decoction(正肝化瘀方,ZGHY) combined with entecavir(ETV) on the gut microbiota in patients with chronic hepatitis B(CHB) fibrosis.METHODS:A total of 59 CHB-related fibrosis patients were enrolled and treated with ZGHY combined with ETV(ZGHY + ETV) and ETV alone.Fecal samples were collected from patients at weeks 0,12,and 24 after treatment and gut microbiota were analyzed by 16S r RNA gene sequencing.RESULTS:Compared to the ETV group,microbiota diversity in the ZGHY + ETV group was increased after 24 weeks.Some potentially pathogenic bacteria,including Fusobacteriaceae spp.,Acidaminococcus spp.,and Erysipelotrichaceae spp.were reduced in the ZGHY + ETV group,while Eubacteriaceae spp.,Lactococcus spp.,and several other beneficial bacteria were increased.CONCLUSION:Decreases in pathogenic bacteria and increases in probiotics were not always observed in the Traditional Chinese Medicine(TCM) group(e.g.,Rothia was abundant).As an adjuvant TCM formulation for ETV,ZGHY had a positive role in the treatment of CHB patients. 展开更多
关键词 hepatitis B CHRONIC FIBROSIS RNA RIBOSOMAL 16S Zhenggan Huayu decoction ENTECAVIR gut microbiota
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部